These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34287384)

  • 21. Effectiveness of CoronaVac among healthcare workers in the setting of high SARS-CoV-2 Gamma variant transmission in Manaus, Brazil: A test-negative case-control study.
    Hitchings MDT; Ranzani OT; Torres MSS; de Oliveira SB; Almiron M; Said R; Borg R; Schulz WL; de Oliveira RD; da Silva PV; de Castro DB; Sampaio VS; de Albuquerque BC; Ramos TCA; Fraxe SHH; da Costa CF; Naveca FG; Siqueira AM; de Araújo WN; Andrews JR; Cummings DAT; Ko AI; Croda J
    Lancet Reg Health Am; 2021 Sep; 1():100025. PubMed ID: 34386791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
    Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
    Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of BNT162b2 and CoronaVac vaccinations against SARS-CoV-2 omicron infection in people aged 60 years or above: a case-control study.
    Wan EYF; Mok AHY; Yan VKC; Chan CIY; Wang B; Lai FTT; Chui CSL; Li X; Wong CKH; Lau CS; Wong ICK; Chan EWY
    J Travel Med; 2022 Dec; 29(8):. PubMed ID: 36250571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimated COVID-19 severe cases and deaths averted in the first year of the vaccination campaign in Brazil: A retrospective observational study.
    Santos CVBD; Noronha TG; Werneck GL; Struchiner CJ; Villela DAM
    Lancet Reg Health Am; 2023 Jan; 17():100418. PubMed ID: 36575682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study.
    Ranzani OT; Hitchings MDT; Dorion M; D'Agostini TL; de Paula RC; de Paula OFP; Villela EFM; Torres MSS; de Oliveira SB; Schulz W; Almiron M; Said R; de Oliveira RD; Vieira da Silva P; de Araújo WN; Gorinchteyn JC; Andrews JR; Cummings DAT; Ko AI; Croda J
    BMJ; 2021 Aug; 374():n2015. PubMed ID: 34417194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of Heterologous Coronavirus Disease 2019 (COVID-19) Vaccine Booster Dosing in Brazilian Healthcare Workers, 2021.
    Marra AR; Miraglia JL; Malheiros DT; Guozhang Y; Teich VD; da Silva Victor E; Rebello Pinho JR; Cypriano A; Vieira LW; Polonio M; Ornelas RH; de Oliveira SM; Borges Junior FA; Oler SCC; Schettino GPP; de Oliveira KG; Ferraz Santana RA; de Mello Malta F; Amgarten D; Boechat AL; Trecenti NMZ; Kobayashi T; Salinas JL; Edmond MB; Rizzo LV
    Clin Infect Dis; 2023 Feb; 76(3):e360-e366. PubMed ID: 35639918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The COVID-19 Humoral Immunological Status Induced by CoronaVac and AstraZeneca Vaccines Significantly Benefits from a Booster Shot with the Pfizer Vaccine.
    Farias JP; da Silva PS; Fogaça MMC; Santana IVR; Luiz WB; Birbrair A; Amorim JH
    J Virol; 2022 Apr; 96(8):e0017722. PubMed ID: 35389263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies.
    Cheetham NJ; Kibble M; Wong A; Silverwood RJ; Knuppel A; Williams DM; Hamilton OKL; Lee PH; Bridger Staatz C; Di Gessa G; Zhu J; Katikireddi SV; Ploubidis GB; Thompson EJ; Bowyer RCE; Zhang X; Abbasian G; Garcia MP; Hart D; Seow J; Graham C; Kouphou N; Acors S; Malim MH; Mitchell RE; Northstone K; Major-Smith D; Matthews S; Breeze T; Crawford M; Molloy L; Kwong ASF; Doores K; Chaturvedi N; Duncan EL; Timpson NJ; Steves CJ
    Elife; 2023 Jan; 12():. PubMed ID: 36692910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Investigation of Humoral and Cellular Immunity in TOBB ETÜ Hospital Workers After Three Doses of CoronaVac Vaccination and after One Dose of Comirnaty Vaccination Following Two Doses of CoronaVac].
    Özyurda F; Ardıçoğlu Akışın Y; Mert T; Poyraz B; Özkan Y; Turan M; Göçmen JS; Yücel A; Akar N
    Mikrobiyol Bul; 2022 Jul; 56(3):387-403. PubMed ID: 35960233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunogenicity and safety of inactivated SARS-CoV-2 vaccine (CoronaVac) using two-dose primary protocol in children and adolescents (Immunita-002, Brazil): A phase IV six-month follow up.
    Corsini CA; Martins PFDS; Filgueiras PS; Lourenço AJ; Lima AES; Gomes SVC; Jeremias WJ; Alves PA; Fernandes GDR; Castro LLME; de Carvalho AT; Azevedo ACC; Curimbaba CAL; Lorencini DA; Junior EM; da Silva VM; Cervi MC; Borges MC; Nogueira ML; Campos GRF; Correa PRL; Carvalho TML; Dos Reis JGAC; Reis EVS; Castilho LDR; de Lima PR; do Nascimento JPR; de Oliveira JG; Filho OAM; Grenfell RFQE;
    Res Sq; 2024 Feb; ():. PubMed ID: 38464059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Change in covid-19 risk over time following vaccination with CoronaVac: test negative case-control study.
    Hitchings MDT; Ranzani OT; Lind ML; Dorion M; D'Agostini TL; de Paula RC; de Paula OFP; de Moura Villela EF; Scaramuzzini Torres MS; de Oliveira SB; Schulz W; Almiron M; Said R; de Oliveira RD; Vieira da Silva P; de Araújo WN; Gorinchteyn JC; Dean NE; Andrews JR; Cummings DAT; Ko AI; Croda J
    BMJ; 2022 Jun; 377():e070102. PubMed ID: 35697361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of two coronavirus disease 2019 (COVID-19) vaccines (viral vector and inactivated viral vaccine) against severe acute respiratory coronavirus virus 2 (SARS-CoV-2) infection in a cohort of healthcare workers.
    Marra AR; Miraglia JL; Malheiros DT; Guozhang Y; Teich VD; da Silva Victor E; Pinho JRR; Cypriano A; Vieira LW; Polonio M; Ornelas RH; de Oliveira SM; Borges Junior FA; Shibata ARO; Schettino GPP; de Oliveira KG; Ferraz Santana RA; de Mello Malta F; Amgarten D; Boechat AL; Trecenti NMZ; Kobayashi T; Salinas JL; Edmond MB; Rizzo LV
    Infect Control Hosp Epidemiol; 2023 Jan; 44(1):75-81. PubMed ID: 35351217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil: a test-negative case-control study.
    Paixao ES; Wong KLM; Alves FJO; de Araújo Oliveira V; Cerqueira-Silva T; Júnior JB; Machado TM; Junior EPP; Boaventura VS; Penna GO; Werneck GL; Rodrigues LC; Pearce N; Barreto ML; Barral-Netto M
    BMC Med; 2022 Apr; 20(1):146. PubMed ID: 35379250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct from the COVID-19 crisis: research and innovation sparks in Brazil.
    Rosa MFF; da Silva EN; Pacheco C; Diógenes MVP; Millett C; Gadelha CAG; Santos LMP
    Health Res Policy Syst; 2021 Jan; 19(1):10. PubMed ID: 33478499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 Study.
    Grenfell RFQ; Almeida NBF; Filgueiras PS; Corsini CA; Gomes SVC; de Miranda DAP; Lourenço AJ; Martins-Filho OA; de Oliveira JG; Teixeira-Carvalho A; Campos GRF; Nogueira ML; Alves PA; Fernandes GR; Castilho LR; Lima TM; de Abreu DPB; Alvim RGF; Silva TBS; Jeremias WJ; Otta DA; Campi-Azevedo AC;
    Front Immunol; 2022; 13():918896. PubMed ID: 35757764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study.
    McMenamin ME; Nealon J; Lin Y; Wong JY; Cheung JK; Lau EHY; Wu P; Leung GM; Cowling BJ
    Lancet Infect Dis; 2022 Oct; 22(10):1435-1443. PubMed ID: 35850128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil.
    Katikireddi SV; Cerqueira-Silva T; Vasileiou E; Robertson C; Amele S; Pan J; Taylor B; Boaventura V; Werneck GL; Flores-Ortiz R; Agrawal U; Docherty AB; McCowan C; McMenamin J; Moore E; Ritchie LD; Rudan I; Shah SA; Shi T; Simpson CR; Barreto ML; Oliveira VA; Barral-Netto M; Sheikh A
    Lancet; 2022 Jan; 399(10319):25-35. PubMed ID: 34942103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population-Based Analysis of the Immunoglobulin G Response to Different COVID-19 Vaccines in Brazil.
    Paula NM; Conzentino MS; Gonçalves ACA; da Silva R; Weissheimer KV; Kluge CHS; Marins PHSA; Camargo HSC; Farias LRP; Sant'Ana TP; Vargas LR; Aldrighi JD; Lima ÊS; Jacotenski GT; Pedrosa FO; Gonçalves AG; Joucoski E; Huergo LF
    Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial.
    Leung NHL; Cheng SMS; Cohen CA; Martín-Sánchez M; Au NYM; Luk LLH; Tsang LCH; Kwan KKH; Chaothai S; Fung LWC; Cheung AWL; Chan KCK; Li JKC; Ng YY; Kaewpreedee P; Jia JZ; Ip DKM; Poon LLM; Leung GM; Peiris JSM; Valkenburg SA; Cowling BJ
    Lancet Microbe; 2023 Sep; 4(9):e670-e682. PubMed ID: 37549680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy of Homologous and Heterologous Vaccine Applications on SARS-CoV-2 Omicron Variant: Cohort of Manisa Celal Bayar University Healthcare Workers].
    Çiçek K; Özkaya Y; Eser E; Buran ZC; Öztürk Arıkan ZÖ; Akçalı S; Erbay Dündar P; Cengiz Özyurt B; Şenol Akar Ş; Özer D; Karadağ Yalçın F
    Mikrobiyol Bul; 2023 Apr; 57(2):238-251. PubMed ID: 37067208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.